
Kiagaba M 300mg/500mcg Tablet
Marketer
Alicanto Drugs Pvt Ltd
Salt Composition
Gabapentin (300mg) + Methylcobalamin (500mcg)
Overview Kiagaba M 300mg/500mcg Tablet
Combiflam N, a 300mg/500mcg tablet formulation, addresses neuropathic pain by regulating nerve cell calcium channels. Administered orally, with or without food, ideally before sleep, consistent daily timing ensures stable drug levels. Follow your physician's prescribed dosage and duration; if a dose is missed, take it immediately upon recall. Complete the treatment regimen, even with symptom improvement. Abrupt cessation requires prior medical consultation. Common adverse effects include nausea, peripheral swelling, gait instability, blurred vision, pyrexia, and involuntary eye movements (nystagmus). Dizziness and somnolence may occur; avoid driving or tasks demanding concentration until the drug's impact is known. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your doctor. Disclose pregnancy, pregnancy plans, or breastfeeding before commencing treatment. While generally compatible with other medications, certain drugs (including antacids and alcohol) may interact, increasing side effect risk.
Uses of Kiagaba M 300mg/500mcg Tablet
Managing neuropathic pain
Major Benefits of Kiagaba M 300mg/500mcg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 300mg/500mcg Kiagaba M Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
Common Side effects of Kiagaba M 300mg/500mcg Tablet:
- Dizziness
- Sleepiness
- Tiredness
- Uncoordinated body movements
How to use Kiagaba M 300mg/500mcg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Kiagaba M 300mg/500mcg Tablets can be consumed with or without food, although consistent daily timing is recommended.
How Kiagaba M 300mg/500mcg Tablet works:
Kiagaba M tablets (300mg Gabapentin/500mcg Methylcobalamin) combine gabapentin, an alpha-2-delta ligand that reduces pain by regulating nerve cell calcium channels, with methylcobalamin, a B vitamin crucial for myelin synthesis. Myelin protects nerve fibers and aids in the repair of damaged nerve cells. This dual action provides effective relief from neuropathic pain.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Kiagaba M 300mg/500mcg tablets and alcohol may lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Kiagaba M 300mg/500mcg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Kiagaba M 300mg/500mcg tablets safely. Available human data indicates minimal risk to the infant. However, infant monitoring for increased sleepiness and weight is recommended.
DrivingUNSAFE
Taking Kiagaba M 300mg/500mcg tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Kiagaba M 300mg/500mcg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Kiagaba M 300mg/500mcg Tablet in individuals with hepatic impairment. Seek medical advice from your physician.
What if you forget to take Kiagaba M 300mg/500mcg Tablet :
Should you forget to take your Kiagaba M 300mg/500mcg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Kiagaba M 300mg/500mcg Tablet
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Nervous System |
